# Telacebec (T) Treatment in Adults With Buruli Ulcer (BU).

> **NCT06481163** · PHASE2 · RECRUITING · sponsor: **Barwon Health** · enrollment: 140 (estimated)

## Conditions studied

- Buruli Ulcer

## Interventions

- **DRUG:** Telacebec

## Key facts

- **NCT ID:** NCT06481163
- **Lead sponsor:** Barwon Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-09
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2025-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06481163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06481163, "Telacebec (T) Treatment in Adults With Buruli Ulcer (BU).". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06481163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*